AOLS - Aeolus Pharmaceuticals, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue2,0763,1119,6313,928
Cost of Revenue2,8813,5096,9663,360
Gross Profit-805-3982,665568
Operating Expenses
Research Development----
Selling General and Administrative2,4682,2282,7453,266
Non Recurring----
Total Operating Expenses5,3495,7379,7116,626
Operating Income or Loss-3,273-2,626-80-2,698
Income from Continuing Operations
Total Other Income/Expenses Net-285-2--510
Earnings Before Interest and Taxes-3,273-2,626-80-2,698
Interest Expense-285-2-2-2
Income Before Tax-3,558-2,628-80-3,208
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-3,558-2,628-80-3,208
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-3,558-2,628-80-3,208
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-6,044-2,628-80-3,208